Top Markets
Coin of the day
HealthBeacon plc HealthBeacon plc

HealthBeacon plc

HBCNF
Kedudukan dalam Saham #33073
HealthBeacon plc functions as a digital therapeutics firm that specializes in... HealthBeacon plc functions as a digital therapeutics firm that specializes in developing technologies to support individuals in overseeing their self-administered injectable medications from the comfort of their homes. Its services are available across Europe, the United States, and Ireland. The company's flagship offering is an injection care management system, meticulously designed to monitor and improve patient compliance and consistent usage of prescribed medication regimens. This is achieved by providing a comprehensive set of tools, which include automated treatment reminders, secure and environmentally responsible sharps disposal containers, patient education resources, and advanced data analysis driven by artificial intelligence. HealthBeacon plc further expands its business by offering these innovative medical adherence devices and injection care management systems through both outright sales and leasing arrangements. The company was founded in 2013 and maintains its headquarters in Dublin, Ireland.
Harga Saham
$0.5
Disegerakkan terakhir: 2024-01-30
Modal Pasaran
$8.45M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
IE
Perdagangan HealthBeacon plc (HBCNF)

Kategori

Pendapatan untuk HealthBeacon plc (HBCNF)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini HealthBeacon plc, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi HealthBeacon plc dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$2.04B -
US
$222.34M -
AU
$295.53M -
US
$-259.89M -
US
- -
US